Last year, researchers claimed the gene-editing method had accuracy issues, but a new whole-genome sequencing analysis by the same team finds otherwise.
For decades, Matthews led two important repositories for fruit fly research: the Bloomington Drosophila Stock Center and FlyBase.
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
Trained in microbiology, Slaughter championed science, women’s health, and consumer protections as a member of the US House of Representatives.
A device dubbed the “mother machine” enables real-time observation of mutagenesis in single bacterial cells.
Analysis of DNA samples from more than 520,000 people brings the number of known stroke-risk loci to 32.
The biologist earned a Nobel Prize in 2002 for his work on C. elegans.
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
A whole-genome analysis of people who experience color when they listen to sounds points to a handful of genes involved in neural development.
Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.
The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
The US Senate narrowly approved the politician, who does not have a science background.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
© 1986-2018 The Scientist
